Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 256–270 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5325 EXT1 Gene (Familial Chondrosarcoma) Genetic Test This genetic test evaluates the EXT1 gene for pathogenic variants associated with hereditary multiple exostoses and increased chondrosarcoma risk.	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EXT1 gene", "Copy number variations (CNVs) in the EXT1 gene"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Coverage", "reference_range": "100% of coding regions ±10 bp"}] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of Hereditary Multiple Exostoses (HME)", "Assessment of chondrosarcoma risk in individuals with HME", "Genetic counseling for families with HME or chondrosarcoma", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 88373-9 ICD-10: Q78.6, C41.9, Z15.09 Clinical summary This genetic test evaluates the EXT1 gene for pathogenic variants associated with hereditary multiple exostoses and increased chondrosarcoma risk.
TEST-3522 EYA1 Gene Analysis for Branchio‑Oto‑Renal Syndrome Type 1 (NGS) Test This test identifies pathogenic variants in the EYA1 gene associated with Branchio‑Oto‑Renal Syndrome Type 1.	Peripheral Whole Blood (3–5 mL in EDTA tube) or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in EYA1 gene", "Full coding exons and flanking intronic regions"] Parameters [] Preparation [] Indications ["Individuals presenting with branchial arch anomalies, sensorineural hearing loss, and renal dysplasia", "Confirmation of Branchio‑Oto‑Renal Syndrome Type 1"] Measurement technique Confirm with laboratory Codes LOINC: 51955-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the EYA1 gene associated with Branchio‑Oto‑Renal Syndrome Type 1.
TEST-3156 F2 Gene (Prothrombin G20210A) Thrombophilia Genetic Test This genetic test identifies the Prothrombin G20210A mutation, a common inherited risk factor for venous thromboembolism.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Prothrombin G20210A mutation", "Rare or novel variants in the F2 gene"] Parameters [] Preparation ["No fasting is required"] Indications ["Personal or family history of venous thromboembolism", "Evaluation of inherited thrombophilia risk"] Measurement technique Confirm with laboratory Codes LOINC: 33956-8 ICD-10: D68.5 Clinical summary This genetic test identifies the Prothrombin G20210A mutation, a common inherited risk factor for venous thromboembolism.
TEST-3931 F5 Gene Budd-Chiari Syndrome Genetic Test This test analyzes the entire coding region of the F5 gene to detect pathogenic mutations associated with Budd-Chiari syndrome and inherited thrombophilia.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the F5 gene", "Presence of known and novel variants"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Patients with Budd-Chiari syndrome", "Patients with unexplained hepatic vein thrombosis", "Patients with a negative traditional thrombophilia panel but high clinical suspicion"] Measurement technique Confirm with laboratory Codes LOINC: 21616-1 ICD-10: Z13.89 Clinical summary This test analyzes the entire coding region of the F5 gene to detect pathogenic mutations associated with Budd-Chiari syndrome and inherited thrombophilia.
TEST-3264 F9 Gene Hemophilia B Next‑Generation Sequencing (NGS) Genetic Test This test analyzes the entire F9 gene for mutations causing factor IX deficiency (hemophilia B).	Whole blood, extracted DNA, or FTA card (dried blood spot)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the F9 gene", "Factor IX deficiency"] Parameters [] Preparation ["Genetic counselling session required", "Continue all prescribed medications"] Indications ["Diagnostic confirmation of hemophilia B", "Carrier screening", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 51677-3 ICD-10: D67 Clinical summary This test analyzes the entire F9 gene for mutations causing factor IX deficiency (hemophilia B).
TEST-1611 Factor II Mutation Screening (F2 Test This test detects the presence of the Factor II (G20210A) gene mutation, a known inherited risk factor for developing blood clots.	Peripheral blood (whole blood)	3–4 working days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Prothrombin gene G20210A variant", "Inherited thrombophilia risk"] Parameters [] Preparation ["No fasting required", "Provide a blood sample with a valid doctor’s prescription (unless exempt for surgical cases, pregnancy-related testing, or travel abroad screening)"] Indications ["Evaluation of personal or family history of VTE", "Pre-surgical screening in high-risk individuals", "Pre-pregnancy screening in high-risk individuals", "Screening for inherited thrombophilia"] Measurement technique Confirm with laboratory Codes LOINC: 21654-8 ICD-10: Z13.79 Clinical summary This test detects the presence of the Factor II (G20210A) gene mutation, a known inherited risk factor for developing blood clots.
TEST-6362 Factor XIIIB Deficiency (F13B Gene) Genetic Test This genetic test identifies pathogenic variants within the F13B gene associated with hereditary Factor XIIIB deficiency.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["F13B gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Inform phlebotomist of any latex or antiseptic allergies", "Ensure patient is stable if experiencing active bleeding"] Indications ["Suspected hereditary Factor XIIIB deficiency", "Family history of bleeding disorders", "Unexplained bleeding"] Measurement technique Confirm with laboratory Codes LOINC: 94465-5 ICD-10: D68.2 Clinical summary This genetic test identifies pathogenic variants within the F13B gene associated with hereditary Factor XIIIB deficiency.
TEST-1953 Familial Pancreatic Cancer‑Melanoma Syndrome (CDKN2A Gene) NGS Test This test evaluates the entire coding region and intron-exon boundaries of the CDKN2A gene for germline mutations associated with increased risk of pancreatic cancer and melanoma.	Peripheral whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN2A gene mutations", "Copy number variants (CNVs) in CDKN2A", "Lifetime risk stratification for pancreatic cancer and melanoma"] Parameters [] Preparation [] Indications ["Individuals with a strong family history of pancreatic cancer, melanoma, or multiple primary malignancies.", "Individuals seeking definitive hereditary risk stratification for these cancers."] Measurement technique Confirm with laboratory Codes LOINC: 94222-0 ICD-10: Z15.09 Clinical summary This test evaluates the entire coding region and intron-exon boundaries of the CDKN2A gene for germline mutations associated with increased risk of pancreatic cancer and melanoma.
TEST-2611 FBN1 Gene Marfan Syndrome Genetic Test This test identifies pathogenic variants in the FBN1 gene associated with Marfan syndrome.	Whole blood or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FBN1 gene", "Copy Number Variations (CNV) in FBN1"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor."] Indications ["Clinical suspicion of Marfan syndrome", "Family screening for Marfan syndrome", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94451-2 ICD-10: Q87.4 Clinical summary This test identifies pathogenic variants in the FBN1 gene associated with Marfan syndrome.
TEST-2608 FBN1 Gene Sequencing for MASS Syndrome (Genetic Test) This test evaluates the FBN1 gene for pathogenic variants associated with MASS syndrome, a connective tissue disorder.	Peripheral whole blood (EDTA), extracted germline DNA, or dried FTA card spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FBN1 gene sequence", "Pathogenic variants in FBN1"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session included"] Indications ["Individuals with clinical features suggestive of MASS syndrome", "First-degree relatives of a proband with a confirmed pathogenic FBN1 variant"] Measurement technique Confirm with laboratory Codes LOINC: 21669-8 ICD-10: Q87.4 Clinical summary This test evaluates the FBN1 gene for pathogenic variants associated with MASS syndrome, a connective tissue disorder.
TEST-3252 FERMT3 Gene (Leukocyte Adhesion Deficiency Type 3) Genetic Test This genetic test evaluates the FERMT3 gene for pathogenic variants associated with Leukocyte Adhesion Deficiency Type 3 (LAD3). It detects single nucleotide polymorphisms (SNPs),...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FERMT3 gene", "Single Nucleotide Polymorphisms (SNPs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No special preparation required", "Ensure child is well-hydrated", "Avoid collection during acute febrile illness"] Indications ["Suspected Leukocyte Adhesion Deficiency Type 3 (LAD3)", "Recurrent severe infections", "Unexplained bleeding diathesis", "Delayed umbilical cord separation"] Measurement technique Confirm with laboratory Codes LOINC: 94222-4 ICD-10: D84.0 Clinical summary This genetic test evaluates the FERMT3 gene for pathogenic variants associated with Leukocyte Adhesion Deficiency Type 3 (LAD3). It detects single nucleotide polymorphisms (SNPs), insertions/deletions (indels), and copy number variants (CNVs) across the entire gene.
TEST-1595 FGFR1 (Solid Tumor) FISH Test This diagnostic test evaluates for the presence of FGFR1 gene amplifications in solid tumor tissue using Fluorescence In-Situ Hybridization (FISH). It provides high diagnostic accu...	Archival Tissue Specimen (Formalin-Fixed Paraffin-Embedded Block or Slides)	7–8 business days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR1 gene amplification", "Fibroblast growth factor receptor 1 gene copy number"] Parameters [] Preparation ["No special preparation is required by the patient.", "Oncologist arranges for tissue biopsy and sends FFPE block or slides."] Indications ["Patients with histologically confirmed malignant solid tumors", "Guiding targeted therapy decisions for FGFR-targeted tyrosine kinase inhibitors", "Identifying patients potentially responsive to treatment in breast, lung, and squamous cell carcinomas"] Measurement technique Confirm with laboratory Codes LOINC: 93350-3 ICD-10: C80.1 Clinical summary This diagnostic test evaluates for the presence of FGFR1 gene amplifications in solid tumor tissue using Fluorescence In-Situ Hybridization (FISH). It provides high diagnostic accuracy (99.9% sensitivity) for guiding targeted therapy decisions.
TEST-2902 FGFR2 Gene Craniosynostosis, Nonspecific Genetic Test This diagnostic test evaluates the entire coding region of the FGFR2 gene for pathogenic variants associated with syndromic craniosynostosis.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR2 gene pathogenic variants", "Mutations causing syndromic craniosynostosis"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting a physician"] Indications ["Suspected syndromic craniosynostosis (Apert, Crouzon, Pfeiffer syndromes)", "Family history of craniosynostosis", "Need for genetic counselling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 54419-9 ICD-10: Q75.0, Q75.1, Q87.0 Clinical summary This diagnostic test evaluates the entire coding region of the FGFR2 gene for pathogenic variants associated with syndromic craniosynostosis.
TEST-5286 FGFR2 Gene Genetic Test for Craniofacial-Skeletal-Dermatologic Dysplasia This genetic test analyzes the entire FGFR2 gene to identify pathogenic variants associated with craniofacial-skeletal-dermatologic dysplasias.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR2 gene", "Copy Number Variations (CNV) in FGFR2"] Parameters [] Preparation ["No specific fasting required.", "Inform lab of any high-dose anticoagulant use."] Indications ["Patients with clinical signs of FGFR2-related syndromes", "Family history of FGFR2-related syndromes", "Newborns with suggestive physical features", "At-risk family members seeking carrier or predictive testing"] Measurement technique Confirm with laboratory Codes LOINC: 81261-5 ICD-10: Q87.0, Q75.1 Clinical summary This genetic test analyzes the entire FGFR2 gene to identify pathogenic variants associated with craniofacial-skeletal-dermatologic dysplasias.
TEST-1601 FGFR3/IgH Translocation FISH Test This test detects the t(4;14) chromosomal translocation, a high-risk genetic marker associated with multiple myeloma.	Bone marrow aspirate or peripheral blood	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["t(4;14) translocation", "FGFR3/IgH gene fusion"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless advised otherwise by a physician"] Indications ["Diagnosis and risk stratification of multiple myeloma", "Suspected or confirmed plasma cell disorders"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: C90.00 Clinical summary This test detects the t(4;14) chromosomal translocation, a high-risk genetic marker associated with multiple myeloma.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories